VORASIDENIB for Malignant oligodendroglioma: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 7 adverse event reports in the FDA FAERS database where VORASIDENIB was used for Malignant oligodendroglioma.
Most Reported Side Effects for VORASIDENIB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Alanine aminotransferase increased | 33 | 12.5% | 0 | 5 |
| Fatigue | 27 | 10.2% | 1 | 2 |
| Aspartate aminotransferase increased | 26 | 9.9% | 0 | 5 |
| Malignant neoplasm progression | 25 | 9.5% | 2 | 3 |
| Seizure | 21 | 8.0% | 0 | 5 |
| Hepatic cytolysis | 18 | 6.8% | 0 | 0 |
| Headache | 17 | 6.4% | 0 | 1 |
| Hepatic enzyme increased | 17 | 6.4% | 0 | 1 |
| Gamma-glutamyltransferase increased | 16 | 6.1% | 0 | 2 |
| Nausea | 16 | 6.1% | 1 | 2 |
| Hepatotoxicity | 13 | 4.9% | 0 | 1 |
| Diarrhoea | 12 | 4.6% | 0 | 1 |
| Drug-induced liver injury | 10 | 3.8% | 0 | 6 |
| Dizziness | 9 | 3.4% | 0 | 2 |
| Fall | 8 | 3.0% | 0 | 2 |
Other Indications for VORASIDENIB
Brain neoplasm malignant (83)
Astrocytoma (42)
Product used for unknown indication (40)
Oligodendroglioma (34)
Glioma (26)
Brain neoplasm (20)
Other Drugs Used for Malignant oligodendroglioma
TEMOZOLOMIDE (40)
VINCRISTINE (11)
BEVACIZUMAB (10)
PROCARBAZINE (9)
LOMUSTINE (7)
OLAPARIB (7)
PEMBROLIZUMAB (5)